Showing results (51-60 of 307) with videos related to
Sort By:
Pageof 31
Current Psychiatry Reports|January 30, 2002
Depression in Parkinson's diseaseTheresa A Zesiewicz, Robert A HauserThe Neurologist|May 15, 2007
Advances in the pharmacologic management of early Parkinson diseaseRobert A Hauser, Theresa A ZesiewiczNeurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 8, 2020
Medical Management and Prevention of Motor Complications in Parkinson's DiseaseStephen D Aradi, Robert A HauserExpert Opinion on Pharmacotherapy|November 24, 2015
Carbidopa levodopa enteral suspensionLauren C Seeberger, Robert A HauserExpert Review of Neurotherapeutics|July 11, 2009
Levodopa/carbidopa/entacapone in Parkinson's diseaseLauren C Seeberger, Robert A HauserExpert Opinion on Pharmacotherapy|July 13, 2017
Valbenazine for the treatment of tardive dyskinesiaLauren C Seeberger, Robert A HauserNeuropharmacology|October 16, 2007
Optimizing bioavailability in the treatment of Parkinson's diseaseLauren C Seeberger, Robert A HauserEuropean Neurology|May 16, 2008
Levodopa-induced dyskinesias in Parkinson's disease: etiology, impact on quality of life, and treatmentsElmyra V Encarnacion, Robert A HauserCNS Drugs|May 31, 2003
Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?Theresa A Zesiewicz, Robert A HauserNeurology|May 24, 2006
Clinical trials aimed at detecting neuroprotection in Parkinson's diseaseRobert A Hauser, Theresa A ZesiewiczPageof 31